PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.02%
Revenue growth 1.25-1.5x MRVL's 6.88%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
5.99%
Gross profit growth at 50-75% of MRVL's 9.28%. Martin Whitman would question if cost structure or brand is lagging.
44.10%
EBIT growth above 1.5x MRVL's 0.09%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
44.10%
Operating income growth above 1.5x MRVL's 0.09%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
29.80%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
25.00%
EPS growth of 25.00% while MRVL is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
23.08%
Diluted EPS growth of 23.08% while MRVL is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
2.33%
Share count expansion well above MRVL's 1.06%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
2.77%
Diluted share count expanding well above MRVL's 1.06%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
62.89%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
770.89%
FCF growth above 1.5x MRVL's 87.66%. David Dodd would verify if the firm’s strategic investments yield superior returns.
162.62%
10Y revenue/share CAGR above 1.5x MRVL's 3.03%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
162.62%
5Y revenue/share CAGR above 1.5x MRVL's 3.03%. David Dodd would look for consistent product or market expansions fueling outperformance.
162.62%
3Y revenue/share CAGR above 1.5x MRVL's 3.03%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
1486.11%
10Y OCF/share CAGR above 1.5x MRVL's 50.15%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1486.11%
5Y OCF/share CAGR above 1.5x MRVL's 50.15%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
1486.11%
3Y OCF/share CAGR above 1.5x MRVL's 50.15%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
294.43%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
294.43%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
294.43%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
403.32%
10Y equity/share CAGR at 50-75% of MRVL's 675.09%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
403.32%
5Y equity/share CAGR at 50-75% of MRVL's 675.09%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
403.32%
3Y equity/share CAGR at 50-75% of MRVL's 675.09%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.26%
Our AR growth while MRVL is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
3.27%
Inventory growth well above MRVL's 1.95%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
9.93%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
11.28%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
1.65%
We have some new debt while MRVL reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
8.31%
R&D growth drastically higher vs. MRVL's 8.86%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
5.48%
SG&A growth well above MRVL's 10.43%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.